UPMC Physicians and Researchers Present at the 2018 American Urological Association Annual Meeting

May 17, 2018

The American Urological Association (AUA) will host its 2018 Annual Meeting in San Francisco from May 18 to 21. UPMC and the University of Pittsburgh will be well-represented in poster presentations, panels, case studies, awards, and educational discussions. Some of these presentations include:

Friday, May 18, 2018

7 – 9 a.m.

Moderated Poster Session 2 GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: QUALITY IMPROVEMENT & PATIENT SAFETY I

Room 3006 @ MCC West

Moderators include: Timothy Averch, MD

 

MP02-03 EVALUATION OF THE RISKS AND BENEFITS OF CT UROGRAPHY FOR ASSESSMENT OF GROSS HEMATURIA

Todd Yecies, MD; Jathin Bandari, MD; Bruce Jacobs, MD, MPH, and Benjamin Davies, MD

 

MP01-10 CONTENT VALIDITY EVIDENCE FOR A NOVEL MIXED REALITY PERCUTANEOUS NEPHROLITHOTOMY SIMULATOR

Mohammed Shahait, MD and Timothy Averch, MD

 

7:30 a.m.

Plenary: Prime Time, Friday Morning Session Esplanade

BR @ MCC South

 

SURGICAL TECHNIQUES: TIPS & TRICKS: AN OPEN MIND

Moderator: Edward Messing

Surgeons Include: Joel Nelson, MD

 

9:30 – 11:30 a.m.

MP09-02 DIFFERENTIAL DISTRIBUTION OF HYPERPOLARIZATION-ACTIVATED CHANNELS IN PEPTIDERGIC AND CHOLINERGIC FIBERS OF THE HUMAN BLADDER

Pradeep Tyagi, PhD, Mahendra Kashyap, PhD, and Naoki Yoshimura, MD, PhD

 

MP09-04 EFFECTS OF TRIPLE INHIBITION OF RECEPTORS OF VEGF, FGF, AND PDGF ON BLADDER DYSFUNCTION AND REMODELING IN MICE WITH SPINAL CORD INJURY

Eiichiro Takaoka, MD; Takahisa Suzuki, MD; Anthony Kanai, PhD, and Naoki Yoshimura, MD, PhD

 

MP09-06 AGE-IMPAIRED PURINE METABOLISM ALTERS BLADDER FUNCTION

Amanda Wolf-Johnston, Del Gillespie, Bronagh McDonnell, PhD; Edwin Jackson, PhD, and Lori Birder, PhD

 

1 – 3 p.m.

MP13-06 CORRELATION OF AGE AND GENDER WITH PATIENTS’ KIDNEY STONE RELATED QUALITY OF LIFE

Timothy Averch, MD

 

MP13-07 INCOME IS STRONGLY ASSOCIATED WITH KIDNEY STONE DISEASE-SPECIFIC QUALITY OF LIFE

Timothy Averch, MD

 

Moderated Poster Session 17 PROSTATE CANCER: LOCALIZED: ACTIVE SURVEILLANCE II

Room 3005 @ MCC West

Moderators Include: Joel Nelson, MD

 

Saturday, May 19, 2018

7 – 9 a.m.

MP25-07 SURGICAL MANAGEMENT OF ADULT ACQUIRED BURIED PENIS: IMPACT ON URINARY AND SEXUAL QUALITY OF LIFE OUTCOMES

Katherine Theisen, MD, Thomas Fuller, MD, and Paul Rusilko, DO

 

7:30 a.m.

PD19-04 BLADDER SENSORY MECHANISM EARLY IMPAIRMENT INDUCES DETRUSOR UNDERACTIVITY (DU) FOLLOWING BLADDER OUTLET OBSTRUCTION (BOO)

Lori Ann Birder, PhD

 

7:40 a.m.

PD19-05 THERAPEUTIC EFFECTS OF PDE9 INHIBITOR IN STORAGE AND VOIDING DYSFUNCTION IN MICE WITH SPINAL CORD INJURY (SCI)

Ei-ichiro Takaoka, Takahisa Suzuki, Joonbeom Kwon, Anthony J. Kanai, William C. de Groat, Naoki Yoshimura

 

8 a.m.

PD19-07 CRH NEURONS OF BARRINGTON’S NUCLEUS ARE NECESSARY BUT NOT SUFFICIENT FOR CO-ORDINATED VOIDING IN MICE

Anthony Kanai, PhD

 

1 – 3 p.m.

MP38-12 URETHRAL DYSFUNCTION AND THERAPEUTIC EFFECTS OF A PDE 5 INHIBITOR (TADALAFIL) IN A RAT MODEL OF NEUROGENIC UNDERACTIVE BLADDER INDUCED BY PELVIC NERVE CRUSH

Naoki Yoshimura, MD, PhD

 

MP39-10 NOVEL CONTRAST MIXTURE ACHIEVES CONTRAST RESOLUTION OF HUMAN BLADDER WALL SUITABLE FOR T1 MAPPING: APPLICATIONS IN INTERSTITIAL CYSTITIS (IC) AND BEYOND

Pradeep Tyagi, PhD; Chan-Hong Moon, PhD; Christopher Chermansky, MD 

 

Moderated Poster Session 44 GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: PRACTICE PATTERNS, QUALITY OF LIFE & SHARED DECISION MAKING I

Room 3006 @ MCC West

Moderators Include: James Dupree, MD

 

MP44-02 CHANGING TRENDS IN THE USE OF CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER IN THE UNITE STATES

Mina Fam*, MD, Jonathan Yabes, PhD, Robert Turner, MD, Michelle Yu, MD, Lee Hugar, MD, MSCR, Jeffrey Gingrich, MD, Benjamin Davies, MD, Bruce Jacobs, MD, MPH

 

MP44-05 COMORBIDITIES AFFECT THE HEALTHRELATED QUALITY OF LIFE OF PATIENTS WITH UROLITHIASIS: CROSS-SECTIONAL ANALYSIS FROM THE NORTH AMERICAN STONE QUALITY OF LIFE CONSORTIUM

Timothy D. Averch, MD

 

MP44-09 MARKETING AND TESTOSTERONE TREATMENT IN THE UNITED STATES

Jathin Bandari, MD, Omar Ayyash, MD, MPH Charles Wessel, MLS, Benjamin Davies, MD

 

MP45-06 BLADDER UROTHELIAL AND AFFERENT DYSFUNCTIONS UNDERLYING BLADDER OVERACTIVITY IN RATS WITH CHEMICALLY INDUCED PROSTATIC INFLAMMATION

Donald B. DeFranco, PhD, Zhou Wang, PhD, c, Naoki Yoshimura, MD, PhD

 

MP45-15 TRANSFORMING GROWTH FACTOR BETA 1 INCREASES BENIGN PROSTATIC LUMINAL EPITHELIAL CELL LAYER PERMEABILITY

Ke Wang, MD, Laura E. Pascal, PhD, Donna Stolz, PhD, Rajiv Dhir, MBBS, MBA, Joel B. Nelson, MD, Zhou Wang, PhD

 

MP48-08 ONCOLOGIC OUTCOMES OF SIMPLE ENUCLEATION PARTIAL NEPHRECTOMY IN SPORADIC TYPE 2 PAPILLARY RENAL CELL CARCINOMA

Avinash Maganty*, MD, MSCR Jathin Bandari, MD, Ronald Hrebinko, MD, Benjamin Davies, MD, Jodi Maranchie, MD, Stephen Jackman, MD

 

Sunday, May 20, 2018

7 – 9 a.m.

MP49-16 NOVEL NON-EVERTED STOMA CREATION DURING ILEAL CONDUIT URINARY DIVERSION: SHORT-TERM OUTCOMES

Katherine Theisen, MD, Avinash Maganty, MD, MSCR, Ronald Hrebinko, MD

 

MP50-19 MODELING THE INCIDENCE OF SECONDARY MALIGNANCY AND SUBSEQUENT MORTALITY RELATED TO IONIZING RADIATION USE IN THE EVALUATION AND MANAGEMENT OF NEPHROLITHIASIS

Todd Yecies*, MD, Michelle Semins, MD

 

MP51-03 THE INFLUENCE OF STEREOTACTIC BODY RADIATION TREATMENT ADOPTION ON PROSTATE CANCER TREATMENT PATTERNS

Bruce Jacobs*, MD, MPH, Jonathan Yabes, PhD, Dwight Heron, MD, FACRO, FACR, Chung-Chou Chang, PhD, Joel Nelson, MD, Jeremy Kahn, MD

 

1 – 3 p.m.

MP63-05 FLUOROSCOPY PULSE RATE AND RADIATION ABSORBED DOSE DEMONSTRATE A NEAR-PERFEC LINEAR CORRELATION

Todd Yecies*, MD, Michelle Semins, MD, Michael Sheetz, Mark Durango, MD, Rajeev Chaudhry, MD

 

1:30 p.m. 1:30

PD47-04 CORRELATION BETWEEN GENOMIC INDEX LESIONS, MULTI-PARAMETRIC MRI AND 68GA-PSMA-PET/CT IMAGING FEATURES IN PRIMARY PROSTATE CANCER

Anette Duensing, MD

3:30 – 5:30 p.m.

MP69-01 COST ANALYSIS OF THE MANAGEMENT OF PEDIATRIC FEBRILE UTI: TRADITIONAL, AAP, AND POPULATIO HEALTH ALGORITHMS

Jathin Bandari*, MD

 

MP69-02 OPEN VERSUS ROBOTIC URETERONEOCYSTOSTOMY FOR PEDIATRIC ESICOURETERAL REFLUX: SYSTEMATIC REVIEW

Glenn M. Cannon, MD

 

MP71-02 REFRAMING READMISSION REDUCTION INCENTIVES AFTER RADICAL CYSTECTOMY

Bruce Jacobs, MD, Ken Urish, MD

 

MP71-04 ASSESSING LABORATORY PARAMETERS AND READMISSIONS AFTER RADICAL CYSTECTOMY

Bruce Jacobs, MD, Ken Urish, MD

 

MP71-20 COMPARATIVE EFFECTIVENESS OF NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN THE MEDICARE BLADDER CANCER POPULATION

Mina Fam, MD, Jonathan Yabes, PhD Robert Turner, MD, Jathin Bandari, MD, Lee Hugar, MD, MSCR, Jeffrey Gingrich, MD, Benjamin Davies, MD, Bruce Jacobs, MD, MPH

 

4:50 p.m. 4:50

PD48-09 DESIGN AND DEVELOPMENT OF THE PEDIATRIC UROLOGY RECOVERY AFTER SURGERY ENDEAVOR (PURSUE) MULTICENTER PILOT AND EXPLORATORY STUDY

Rajeev Chaudhry, MD

 

PD50-09 CHARACTERIZATION OF BLADDER DYSFUNCTION INDUCED BY OVARIECTOMY IN MICE

Including: Naoki Yoshimura, MD, PhD

 

Monday, May 21, 2018

7 – 9 a.m.

MP76-19 EXTREME PRICE VARIATION IN GENERIC BENIGN PROSTATIC HYPERPLASIA AND OVERACTIVE BLADDER DRUGS

Katherine Theisen, MD, Seo Young Park, PhD, Jathin Bandari, MD, Bruce Jacobs, MD, MPH, Benjamin Davies, MD

 

7:30 a.m. 7:30 PD55-04 TIBIAL AND PUDENDAL NEUROMODULATION OF SPINAL NEURON ACTIVITY INDUCED BY BLADDER DISTENTION

Including: Todd Yecies*, MD, Yan Zhang,PhD, James Roppolo, PhD, William De Groat, PhD, Changfeng Tai, PhD

 

7:40 a.m.

Podium Session 55 BLADDER & URETHRA: ANATOMY, PHYSIOLOGY & PHARMACOLOGY II

Room 2011 @ MCC West

Moderators: Nissrine Nakib, MD, Michael Ruggieri, PhD, and Lori Birder, PhD

 

PD55-05 THERAPEUTIC EFFECTS OF P38 MAP KINASE INHIBITOR ON BLADDER DYSFUNCTION IN MICE WITH SPINAL CORD INJURY (SCI)

Including: Anthony J. Kanai, PhD, William C. de Groat, PhD, Naoki Yoshimura, MD, PhD

 

9:30 – 11:30 a.m.

MP80-17 MODELING THE RISK OF RADIATION FROM CT UROGRAPHY IN THE EVALUATION OF ASYMPTOMATIC MICROSCOPIC HEMATURIA

Todd Yecies, MD, Jathin Bandari, MD, Benjamin Davies, MD, Bruce Jacobs, MD, MPH

 

1 – 3 p.m.

MP86-16 SPILLOVER EFFECTS OF THE HOSPITAL READMISSION REDUCTION PROGRAM ON RADICAL CYSTECTOMY READMISSIONS

Bruce Jacobs, MD, MPH

MP86-20 PRIMARY TESTICULAR LYMPHOMA: ONCOLOGIC OUTCOMES AND TREATMENT PATTERNS

Mazen Alsinnawi, MD

 

MP89-19 WISCONSIN STONE QUALITY OF LIFE QUESTIONNAIRE: IS STONE REMOVAL SURGERY ASSOCIATED WITH BETTER QUALITY OF LIFE?

Timothy Averch, MD